CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
AMBU Aura-I/aScope 2 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01656967
NCT01656967N/ACompleted
CompareCT.gov

Flexible Optical Intubation Via the AMBU Aura-I Versus Blind Intubation Via the Fastrach Single Use Intubating LMA - A Prospective Randomized Clinical Trial

The University of Texas Health Science Center, Houston·interventional·Posted Aug 3, 2012·Updated Nov 8, 2018

In Brief

A clinical study evaluating AMBU Aura-I/aScope 2 and LMA Fastrach Single Use for Supraglottic Airway. Completed, enrolled 66 participants across 1 site.

Detailed Summary

The purpose of this study is to compare two types of supraglottic airways (SGA), the Ambu® Aura-I and the Intubating Laryngeal Mask Airway (ILMA), regarding time to intubate, ease of insertion, sealing properties, optical view upon fiberoptic examination regarding the Ambu Aura-I, ease and success rate of intubation, airway morbidity, and patient comfort in patients undergoing general anesthesia for elective surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSupraglottic Airway
CountriesUnited States
CollaboratorsAmbu A/S

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 3, 2012
Enrollment StartJul 1, 2010
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 13.9 years ago

Interventions

AMBU Aura-I/aScope 2device

Once ventilation is achieved, the patients in group A will be intubated through the shaft of Aura-I via the the Ambu aScope.

LMA Fastrach Single Usedevice

The patients in group B will be intubated by ETT via the Intubating LMA as is standard procedure.